Investors Should Watch: Array BioPharma, Inc. (NASDAQ:ARRY), Comcast Corporation (NASDAQ:CMCSA), Tech Data Corp. (NASDAQ:TECD), Worthington Industries, Inc. (NYSE:WOR), LDR Holding Corporation (NASDAQ:LDRH)

On Dec 12, Oncothyreon Inc. announced that Array BioPharma, Inc. (NASDAQ:ARRY) has granted Oncothyreon an exclusive license to develop, manufacture and commercialize ONT-380 (ARRY-380), an orally active, reversible and selective small molecule HER2 inhibitor. The license agreement replaces the prior Development and Collaboration Agreement under which Oncothyreon and Array were jointly developing ONT-380. Array BioPharma, Inc. (NASDAQ:ARRY) belongs to Healthcare sector. Its weekly performance is … Continue reading Investors Should Watch: Array BioPharma, Inc. (NASDAQ:ARRY), Comcast Corporation (NASDAQ:CMCSA), Tech Data Corp. (NASDAQ:TECD), Worthington Industries, Inc. (NYSE:WOR), LDR Holding Corporation (NASDAQ:LDRH)

Why Need to Watch: Array BioPharma, Inc. (NASDAQ:ARRY), Hewlett-Packard Company (NYSE:HPQ), Polycom, Inc. (NASDAQ:PLCM), Endurance International Group (NASDAQ:EIGI), Diamond Offshore Drilling (NYSE:DO)

Array BioPharma, Inc. (NASDAQ:ARRY) announced that it has reached a definitive agreement with Novartis International Pharmaceutical Ltd. to regain full worldwide rights to binimetinib, a MEK inhibitor in three Phase 3 trials. This agreement is conditional on the closing of transactions announced by Novartis and GlaxoSmithKline PLC on April 22, 2014, which are expected in the first half of 2015, and remain subject to regulatory … Continue reading Why Need to Watch: Array BioPharma, Inc. (NASDAQ:ARRY), Hewlett-Packard Company (NYSE:HPQ), Polycom, Inc. (NASDAQ:PLCM), Endurance International Group (NASDAQ:EIGI), Diamond Offshore Drilling (NYSE:DO)

Array Biopharma (NASDAQ:ARRY) released its earnings data on Tuesday. The company reported ($0.21) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.22) by $0.01. The company had revenue of $6.07 million for the quarter, compared to the consensus estimate of $6.35 million. During the same quarter in the prior year, the company posted ($0.13) earnings per share. The company’s quarterly revenue was … Continue reading Today’s Watch List: Array BioPharma, Inc. (NASDAQ:ARRY), Fairchild Semiconductor International Inc. (NASDAQ:FCS), Flowserve Corp. (NYSE:FLS), Red Hat, Inc. (NYSE:RHT), JBSS

ProQR Therapeutics N.V. (NASDAQ:PRQR) announced today the closing of its initial public offering of 8,625,000 ordinary shares at a public offering price of $13.00 per share, which includes the exercise in full by the underwriters of their option to purchase 1,125,000 additional ordinary shares. The aggregate net proceeds to the Company, after underwriting discounts and commissions and other estimated offering expenses, will be approximately $102 … Continue reading Shining on Major News : ProQR Therapeutics (NASDAQ:PRQR), Array BioPharma (NASDAQ:ARRY), Brooks Automation (NASDAQ:BRKS), Taubman Centers, Inc. (NYSE:TCO),GERN

Macy’s, Inc. (NYSE:M) is a chain of departmental stores that sells an assortment of fashion products for both men and women.Best Buy Co Inc (NYSE:BBY) sells electronics such as computers, cellphones, video games, and several other tech products. On the other hand, Time Warner Cable Inc (NYSE:TWC) is a cable telecommunications company that operates in many US States.Macy’s, Inc. (NYSE:M) belongs to Services sector. Its … Continue reading Fast Moving Stocks: Macy’s, Inc. (NYSE:M), Array BioPharma (NASDAQ:ARRY), British American Tobacco (NYSEMKT:BTI), Crossroads Systems, Inc. (NASDAQ:CRDS), Clovis Oncology, Inc. (NASDAQ:CLVS)

PharMerica Corporation (NYSE:PMC) reported its financial results for the second quarter and six months ended June 30, 2014. Revenues for the second quarter of 2014 were $448.6 million compared with $430.8 million for the second quarter of 2013. The increase in revenue was primarily the result of the fourth quarter 2013 acquisitions and branded drug price inflation, and was partially offset by previously disclosed bed … Continue reading Morning Buzz: PharMerica (NYSE:PMC), Array BioPharma (NASDAQ:ARRY), Mobile Mini (NASDAQ:MINI), Genocea Biosciences, Inc. (NASDAQ:GNCA), Health Care REIT, Inc. (NYSE:HCN)